<?xml version="1.0" encoding="UTF-8"?>
<p id="para1580">Data on HBV seroprevalence in India are available from blood-bank screening and a few community-based studies, with marked variation across studies.
 <xref rid="bib18" ref-type="bibr">
  <sup>18</sup>
 </xref> On the basis of data from 19 studies from the mid-1990s,
 <xref rid="bib19" ref-type="bibr">
  <sup>19</sup>
 </xref> the prevalence of HBV infection was estimated at 4·7%. Subsequent literature reviews and meta-analyses have provided estimates of 2·4% and 3·7%.
 <xref rid="bib20" ref-type="bibr">20</xref>, 
 <xref rid="bib21" ref-type="bibr">21</xref> A 2015 global systematic review of HBV prevalence included 129 studies from India; of these, 24 reported (with 46 463 participants) data up to 1989 and 106 (3·7 million people) thereafter.
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref> Pooled prevalence was estimated at 2·6% before 1989 and 1·4% after.
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref> A 2018 modelling study found that the prevalence of HBsAg in India in 2016 was 2·5% (95% CI 2·2–2·7).
 <xref rid="bib7" ref-type="bibr">
  <sup>7</sup>
 </xref> Some tribal groups have a higher prevalence of HBV infection than the general population;
 <xref rid="bib18" ref-type="bibr">
  <sup>18</sup>
 </xref> however, these subpopulations are small and their disease burden was deemed unlikely to influence the overall estimates.
</p>
